186 related articles for article (PubMed ID: 24671558)
1. Potential impact of different cytomegalovirus (CMV) IgM assays on an algorithm requiring IgM reactivity as a criterion for measuring CMV IgG avidity.
Prince HE; Lapé-Nixon M; Brenner A; Pitstick N; Couturier MR
Clin Vaccine Immunol; 2014 Jun; 21(6):813-6. PubMed ID: 24671558
[TBL] [Abstract][Full Text] [Related]
2. Performance of a cytomegalovirus IgG enzyme immunoassay kit modified to measure avidity.
Prince HE; Lapé-Nixon M; Novak-Weekley SM
Clin Vaccine Immunol; 2014 Jun; 21(6):808-12. PubMed ID: 24671557
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay.
Lazzarotto T; Galli C; Pulvirenti R; Rescaldani R; Vezzo R; La Gioia A; Martinelli C; La Rocca S; Agresti G; Grillner L; Nordin M; van Ranst M; Combs B; Maine GT; Landini MP
Clin Diagn Lab Immunol; 2001 Jan; 8(1):196-8. PubMed ID: 11139220
[TBL] [Abstract][Full Text] [Related]
4. Validation of an in-house assay for cytomegalovirus immunoglobulin G (CMV IgG) avidity and relationship of avidity to CMV IgM levels.
Prince HE; Leber AL
Clin Diagn Lab Immunol; 2002 Jul; 9(4):824-7. PubMed ID: 12093680
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the indirect and IgM-capture anti-human cytomegalovirus IgM ELISA methods as confirmed by cytomegalovirus IgG avidity.
Ikuta K; Koshizuka T; Kanno R; Inoue N; Kubo T; Koyano S; Suzutani T
Microbiol Immunol; 2019 May; 63(5):172-178. PubMed ID: 31012489
[TBL] [Abstract][Full Text] [Related]
6. National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity.
Dollard SC; Staras SA; Amin MM; Schmid DS; Cannon MJ
Clin Vaccine Immunol; 2011 Nov; 18(11):1895-9. PubMed ID: 21918114
[TBL] [Abstract][Full Text] [Related]
7. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.
Dangel V; Bäder U; Enders G
J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays.
Lagrou K; Bodeus M; Van Ranst M; Goubau P
J Clin Microbiol; 2009 Jun; 47(6):1695-9. PubMed ID: 19339470
[TBL] [Abstract][Full Text] [Related]
9. Serologic screening of pregnant Korean women for primary human cytomegalovirus infection using IgG avidity test.
Seo S; Cho Y; Park J
Korean J Lab Med; 2009 Dec; 29(6):557-62. PubMed ID: 20046088
[TBL] [Abstract][Full Text] [Related]
10. Measurement of the sensitivity of different commercial assays in the diagnosis of CMV infection in pregnancy.
Gentile M; Galli C; Pagnotti P; Di Marco P; Tzantzoglou S; Bellomi F; Ferreri ML; Selvaggi C; Antonelli G
Eur J Clin Microbiol Infect Dis; 2009 Aug; 28(8):977-81. PubMed ID: 19360443
[TBL] [Abstract][Full Text] [Related]
11. Primary cytomegalovirus infection in pregnant Egyptian women confirmed by cytomegalovirus IgG avidity testing.
Kamel N; Metwally L; Gomaa N; Sayed Ahmed WA; Lotfi M; Younis S
Med Princ Pract; 2014; 23(1):29-33. PubMed ID: 24052007
[TBL] [Abstract][Full Text] [Related]
12. Improving diagnosis of primary cytomegalovirus infection in pregnant women using immunoblots.
Rajasekariah H; Scott G; Robertson PW; Rawlinson WD
J Med Virol; 2013 Feb; 85(2):315-9. PubMed ID: 23171986
[TBL] [Abstract][Full Text] [Related]
13. Multiplex detection of IgM and IgG class antibodies to Toxoplasma gondii, rubella virus, and cytomegalovirus using a novel multiplex flow immunoassay.
Binnicker MJ; Jespersen DJ; Harring JA
Clin Vaccine Immunol; 2010 Nov; 17(11):1734-8. PubMed ID: 20861325
[TBL] [Abstract][Full Text] [Related]
14. The role of IgG avidity in diagnosis of cytomegalovirus infection in newborns and infants.
Vilibić-Cavlek T; Ljubin-Sternak S; Vojnović G; Sviben M; Mlinarić-Galinović G
Coll Antropol; 2012 Mar; 36(1):297-300. PubMed ID: 22816235
[TBL] [Abstract][Full Text] [Related]
15. Maternal immunoglobulin G avidity as a diagnostic tool to identify pregnant women at risk of congenital cytomegalovirus infection.
Kaneko M; Ohhashi M; Minematsu T; Muraoka J; Kusumoto K; Sameshima H
J Infect Chemother; 2017 Mar; 23(3):173-176. PubMed ID: 28034524
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of CMV seroconversion in a Swiss pregnant women population.
Maine GT; Stricker R; Stricker R
Diagn Microbiol Infect Dis; 2012 Jul; 73(3):275-7. PubMed ID: 22541330
[TBL] [Abstract][Full Text] [Related]
17. Positive predictive values of CMV-IgM and importance of CMV-IgG avidity testing in detecting primary infection in three different clinical settings. A French retrospective cohort study.
Périllaud-Dubois C; Bouthry E; Jadoui A; Leng AL; Roque-Afonso AM; Vauloup-Fellous C
J Clin Virol; 2020 Nov; 132():104641. PubMed ID: 32947202
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of two novel enzyme immunoassays using recombinant antigens to detect cytomegalovirus-specific immunoglobulin M in sera from pregnant women.
Daiminger A; Bäder U; Eggers M; Lazzarotto T; Enders G
J Clin Virol; 1999 Aug; 13(3):161-71. PubMed ID: 10443792
[TBL] [Abstract][Full Text] [Related]
19. The combination of specific IgM antibodies and IgG antibodies of low avidity does not always indicate primary infection with cytomegalovirus.
Lumley S; Patel M; Griffiths PD
J Med Virol; 2014 May; 86(5):834-7. PubMed ID: 24395084
[TBL] [Abstract][Full Text] [Related]
20. Combination of line immunoassays Mikrogen recomLine CMV IgG and recomLine CMV IgG Avidity helps to date the onset of CMV primary infection.
Delforge ML; Eykmans J; Steensels D; Costa E; Donner C; Montesinos I
Diagn Microbiol Infect Dis; 2019 Mar; 93(3):208-212. PubMed ID: 30361044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
